David A. Schwartz

Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections

David A. Schwartz, Ashley Graham · Viruses · 2020 · 948 citations · Full text

Predictors of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality

Mitchell J. Schwaber, Shiri Klarfeld-Lidji, Shiri Navon‐Venezia et al. · Antimicrobial Agents and Chemotherapy · 2007 · 482 citations · Full text

Klebsiella Pneumoniae, Logistic Analysis, Drug Resistance +17

Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing <i>Enterobacteriaceae</i>

Mitchell J. Schwaber, Shiri Navon‐Venezia, Keith S. Kaye et al. · Antimicrobial Agents and Chemotherapy · 2006 · 408 citations · Full text

Non-esbl Producers, Esbl-producing Escherichia Coli, Antimicrobial Stewardship +14

Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats.

Matthew J. Abrams, Malik E. Juweid, C I tenKate et al. · PubMed · 1990 · 361 citations

Technetium-99m-human Polyclonal Igg, Immunocytochemical Technique, Engineering +28

Adalimumab for the treatment of fistulas in patients with Crohn’s disease

J F Colombel, David A. Schwartz, William J. Sandborn et al. · Gut · 2009 · 351 citations · Full text